Beyond the Granuloma: Rethinking Treatment Strategies for Generalized Granuloma Annulare
Long considered a therapeutic challenge, generalized granuloma annulare (GGA) continues to defy many conventional treatment approaches. While topical steroids may suffice for localized forms, GGA often demands more—and delivers less in return.
This comprehensive review explores the limitations of traditional therapies and highlights the potential of newer systemic agents, including TNF-α inhibitors and JAK inhibitors. With emerging data suggesting higher efficacy and faster onset of action, these advanced treatments could be redefining the standard of care for GGA.
But are they the answer clinicians have been waiting for? Dive into the data and evolving landscape of GGA management.
J Drugs Dermatol. 2025;24(4):425-426.
